C Sense

C-sense is a company offering intelligent sensors for a variety of applications. The primary goal is change and novelty detection followed by feature extraction to determine and identify objects, and, if needed track these.

CanimGuide Therapeutics AB

CanimGuide is a company with a novel, simple but sophisticated and highly innovative, peptide approach to immuno-oncology.

Elander Systems AB

Equipment for Laboratory, R&D, Pilot Plant and Industry More than 35 year of experience in the pharma sector. BIOPROCESS FERMENTERS ; ASEPTIC PROCESSES ; FREEZE DRYING ; CLEANROOMS, LAFs & Air ; FILLING, CLOSING OF VIALS & SYRENGES ; WFI DISTILLATION & Pure Steam. www.aqua-zero.se ; phn: +46 73 755 47 75

Paras Biopharma

Paras Biopharmaceuticals Finland Oy is an up-and-coming biopharmaceutical technology development company which has successfully developed the Diabrid Platform Technology proprietary for the high level expression of biosimilars in specially designed genetically stable clones.

Pharm-analyt

For pharm-analyt quantifying PEGylated substances has been a specialty for more than a decade becoming a core competence in the last 2 years. The most refined and up-to-date method has a calibration range of 20 to 1,000 ng/mL for a > 50 kDa PEG in plasma.

Prostatype Genomics AB

The company Chundsell Medicals AB was founded in 2007 as a spin off from Cancer Center Karolinska (Karolinska Institutet, Stockholm, Sweden) in order to transfer the research results of Dr. Chunde Li and his group into clinical reality.

RhoVac AB

RhoVac is a pharmaceutical company dedicated to immuno-oncology, signifying that the body’s own immune system is stimulated to identify and destroy cancer cells. The primary focus of RhoVac is to develop a cancer therapy that targets metastases to prevent cancer recurrence and progression after primary tumour therapy.

Spago Nanomedical

Spago Nanomedical AB is a Swedish company performing research and development within nanomedicine. Focus is the development of nanomaterials for tumor diagnostics and treatment of cancer. The main development projects SpagoPix and Tumorad are both built on proprietary nanomaterials

WntResearch

WntResearch utvecklar en ny typ av cancerläkemedel baserat på banbrytande forskning som visar att det kroppsegna proteinet Wnt-5a spelar en viktig roll för tumörcellernas förmåga att förflytta och sprida sig i kroppen.